咨詢: (重慶) (貴陽) GMP Recombinant Human Interleukin-4 (rh IL-4), USP grade USP級人重組白介素4產(chǎn)品信息: Data Sheet: CellGro®/ CellGenix™ GMP Recombinant Human Interleukin-4 (rh IL-4), USP grade Order No.: 1003-050 Source A DNA sequence encoding the mature IL-4 protein (Yakota, T. et al., 1986, PNAS 83:5894) was expressed in E. coli Molecular mass The methionyl form of the E. coli expressed mature human IL-4 contains 130 amino acid residues and has a molecular mass of 14 kDa Identity Confirmed by DNA-sequencing of the expression plasmid in end of production (EOP)-cells, Western Blot, and N-terminal sequencing of the final product Purity ≥97%, as determined by SDS-PAGE (under reducing and non-reducing conditions) and visualized by Silver staining Endotoxin level < 50 EU/mg, as determined by LAL gel clot test according to Ph.Eur. Residual host-cell DNA ≤1 ng/mg, as determined with the Threshold®system Activity 0.5x107 – 2x107 USP units per mg1 Measured in a cell proliferation assay using a human factor-dependent cell line, TF-1 (Kitamura, T. et al., 1989, J. Cell Physiol. 140:323-334) USP units are equivalent to international units (IU) Sterility Sterility test according to Ph.Eur. of the vialed product (direct inoculation) Formulation Lyophilized from a 250 μg/ml, 0.2μm sterile-filtered solution in PBS without any carrier materials and preservatives Amount per vial 50 ± 7.5 μg, as determined by spectrophotometrical measurement at 280 nm using PBS as reference (A280= 0.63 for a concentration of 1 mg/ml IL-4 in PBS) Transport Ambient temperature Storage at -20°C or below. Avoid repeated freeze-thaw cycles Shelf life Minimum 6 months from date of shipping Intended use For clinical ex vivo use. Not intended for human in vivo application Quality statement This product is manufactured, tested and released in compliance with the relevant GMP-guidelines. No animal- or human-derived materials were used during manufacturing. This product complies with USP chapter “growth factors and cytokines used in cell therapy manufacturing”. USP chapter “ancillary materials for cell, gene, and tissue-engineered products” has been considered in the design of this product. 更多產(chǎn)品: CellGro® GMP Cytokines | DataSheet_GMP_Activin_A_ZY-DS-1022a.pdf | | DataSheet_GMP_EGF_ZY-DS-1016a.pdf | | DataSheet_GMP_FGF-2_ZY-DS-1021a.pdf | | DataSheet_GMP_Flt-3L_ZY-DS-1015a.pdf | | DataSheet_GMP_GM-CSF_ZY-DS-1012a.pdf | | DataSheet_GMP_IL-10_ZY-DS-1014a.pdf | | DataSheet_GMP_IL-15_ZY-DS-1013a.pdf | | DataSheet_GMP_IL-1beta_ZY-DS-1011b.pdf | | DataSheet_GMP_IL-21_ZY-DS-1019a.pdf | | DataSheet_GMP_IL-2_ZY-DS-1020a.pdf | | DataSheet_GMP_IL-3_ZY-DS-1002c.pdf | | DataSheet_GMP_IL-4_ZY-DS-1003b.pdf | | DataSheet_GMP_IL-6_ZY-DS-1004b.pdf | | DataSheet_GMP_IL-7_ZY-DS-1010a.pdf | | DataSheet_GMP_PDGF-BB_ZY-DS-1009b.pdf | | DataSheet_GMP_SCF_ZY-DS-1018a.pdf | | DataSheet_GMP_TNFalpha_ZY-DS-1006a.pdf | | DataSheet_GMP_TPO_ZY-DS-1017a.pdf |
CellGro® Preclinical Cytokines | DataSheet_preclinical_Activin_A_ZY-DS-1422b.pdf | | DataSheet_preclinical_EGF_ZY-DS-1416a.pdf | | DataSheet_preclinical_FGF-2_ZY-DS-1421a.pdf | | DataSheet_preclinical_Flt-3L_ZY-DS-1415a.pdf | | DataSheet_preclinical_GM-CSF_ZY-DS-1412a.pdf | | DataSheet_preclinical_IL-10_ZY-DS-1414a.pdf | | DataSheet_preclinical_IL-15_ZY-DS-1415a.pdf | | DataSheet_preclinical_IL-1beta_ZY-DS-1411a.pdf | | DataSheet_preclinical_IL-21_ZY-DS-1419a.pdf | | DataSheet_preclinical_IL-2_ZY-DS-1420a.pdf | | DataSheet_preclinical_IL-3_ZY-DS-1402a.pdf | | DataSheet_preclinical_IL-4_ZY-DS-1403a.pdf | | DataSheet_preclinical_IL-6_ZY-DS-1404a.pdf | | DataSheet_preclinical_IL-7_ZY-DS-1410a.pdf | | DataSheet_preclinical_PDGF-BB_ZY-DS-1409a.pdf | | DataSheet_preclinical_SCF_ZY-DS-1418a.pdf | | DataSheet_preclinical_TNFalpha_ZY-DS-1406a.pdf | | DataSheet_preclinical_TPO_ZY-DS-1417a.pdf |
更多詳情請來電: : 重慶市華雅干細(xì)胞技術(shù)有限公司 |